Search | IOVS | ARVO Journals

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2015

Metabolic hallmarks of visual cortex neurodegeneration in DBA/2J mouse model of glaucoma, a proton magnetic resonance spectroscopy study

Michal Fiedorowicz; Jaroslaw Orzel; Bartosz Kossowski; Marlena Welniak-Kaminska; Piotr Bogorodzki; Pawel Grieb

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2451. doi:

ARVO Annual Meeting Abstract June 2015

Eye morphology quantitated by magnetic resonance imaging in C57Bl/6 mice

Tomasz Jakub Choragiewicz; Michal Fiedorowicz; Marlena Welniak-Kaminska; Jaroslaw Orzel; Piotr Bogorodzki; Robert Rejdak; Pawel Grieb

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4082. doi:

ARVO Annual Meeting Abstract April 2009

Effects of Combined- vs. Monotherapy in CNV-Induced Albino Rabbits

T. Herbort; M. J. Koss; S. Julien; M. Pfister; T. J. Choragiewicz; M. Pietras; S. Cisiecki; P. Grieb; U. Schraermeyer; R. Rejdak

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):743. doi:

ARVO Annual Meeting Abstract May 2008

Age-Dependent Neuroprotection of Retinal Ganglion Cells by Tempol C8-acyl Ester in a Rat NMDA Toxicity Model

M. Fiedorowicz; S. Thaler; R. Rejdak; F. Schuettauf; E. Zrenner; M. Wozniak; P. Grieb

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):868. doi:

ARVO Annual Meeting Abstract May 2008

Protective Effect of Tempol From Light- Induced Retinal Degeneration in Brown- Norway Rats

A. D. Baryluk; A. Messias; S. Thaler; R. Rejdak; M. Fiedorowicz; S. Bolz; T. arnowski; F. Gekeler; P. Grieb; E. Zrenner

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1690. doi:

ARVO Annual Meeting Abstract May 2007

Neuroprotective Effects of Tempol and Its Acyl Esters in a Rat Partial Optic Nerve Crush Model

S. Thaler; F. Schuettauf; R. Rejdak; T. J. Choragiewicz; T. Zarnowski; E. Zrenner; Z. Wypych; N. Knap; M. Wozniak; P. Grieb

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):3286. doi:

ARVO Annual Meeting Abstract May 2005

Tempol Protects RGC Against Partial Optic Verve Crush With and Without Iron Load in the Rat

F. Schuettauf; R.A. Rejdak; S. Thaler; K. Dietrich; Z. Zagorski; E. Zrenner; P. Grieb

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1263. doi:

ARVO Annual Meeting Abstract May 2005

Synthesis of Kynurenic Acid, a Tryptophan Derivative in Cataractous Lenses

T. Zarnowski; R. Rejdak; C. Rummelt; E. Zielinska–Rzecka; P. Grieb; W.A. Turski; E. Zrenner; Z. Zagorski; A.M. Junemann

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2884. doi:

ARVO Annual Meeting Abstract May 2005

Vitreous Nitrite/Nitrate Concentrations Are Increased in Patients With Retinal Detachement and Malignant Glaucoma

A. Mankowska; R.A. Rejdak; T. Zarnowski; E. Zielinska; K. Nowomiejska; K. Rejdak; P. Grieb; Z. Zagorski

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5182. doi:

ARVO Annual Meeting Abstract May 2004

Citicoline and/or lithium rescue retinal ganglion cells following callibrated partial optic nerve crush in the rat

R.A. Rejdak; F. Schuettauf; C. Lehaci; S. Thaler; S. Bolz; T. Zarnowski; Z. Zagorski; P. Grieb; E. Zrenner

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):827. doi:

ARVO Annual Meeting Abstract May 2004

Retinal neurodegeneration in the DBA/2J mouse – a model for ocular hypertension

S. Thaler; F. Schuettauf; R. Rejdak; M. Walski; M. Frontczak–Baniewicz; M. Voelker; K. Shinoda; Z. Zagorski; E. Zrenner; P. Grieb

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):892. doi:

ARVO Annual Meeting Abstract May 2003

Alterations of Kynurenic Acid (KYNA) Formation in the Retina of DBA/2J Mice

R.A. Rejdak; F. Schuattauf; Y. Shenk; T. Zarnowski; P. Grieb; W.A. Turski; Z. Zagorski; K. Kohler; E. Zrenner

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):106. doi:

Advertisement